Suppr超能文献

相似文献

1
Inverse Association between Omega-3 Index and Severity of COVID-19: A Case-Control Study.
Int J Environ Res Public Health. 2022 May 25;19(11):6445. doi: 10.3390/ijerph19116445.
2
Omega-3 Index and Clinical Outcomes of Severe COVID-19: Preliminary Results of a Cross-Sectional Study.
Int J Environ Res Public Health. 2021 Jul 21;18(15):7722. doi: 10.3390/ijerph18157722.
3
Association between blood N-3 fatty acid levels and the risk of coronavirus disease 2019 in the UK Biobank.
Am J Clin Nutr. 2023 Feb;117(2):357-363. doi: 10.1016/j.ajcnut.2022.11.011.
4
The effect of polyunsaturated fatty acids on the severity and mortality of COVID patients: A systematic review.
Life Sci. 2022 Jun 15;299:120489. doi: 10.1016/j.lfs.2022.120489. Epub 2022 Mar 28.
5
Unsaturated fatty acids, omega-3 index and hospitalization in MISC.
Prostaglandins Leukot Essent Fatty Acids. 2024 Mar;202:102627. doi: 10.1016/j.plefa.2024.102627. Epub 2024 Jul 1.
9
Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
Nutrition. 2021 Jan;81:110900. doi: 10.1016/j.nut.2020.110900. Epub 2020 Jun 20.

引用本文的文献

2
Risk of secondhand smoke exposure and severity of COVID-19 infection: multicenter case-control study.
Front Public Health. 2023 Aug 3;11:1210102. doi: 10.3389/fpubh.2023.1210102. eCollection 2023.
3
Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.
Signal Transduct Target Ther. 2023 Jun 7;8(1):237. doi: 10.1038/s41392-023-01510-8.
5
Association between blood N-3 fatty acid levels and the risk of coronavirus disease 2019 in the UK Biobank.
Am J Clin Nutr. 2023 Feb;117(2):357-363. doi: 10.1016/j.ajcnut.2022.11.011.
6
Bioactive omega-3 fatty acids are associated with reduced risk and severity of SARS-CoV-2 infection.
Am J Clin Nutr. 2023 Feb;117(2):213-215. doi: 10.1016/j.ajcnut.2022.12.007.

本文引用的文献

2
Potential of Omega 3 Supplementation for Coronavirus Disease 2019 (COVID-19): A Scoping Review.
Int J Gen Med. 2022 Apr 11;15:3915-3922. doi: 10.2147/IJGM.S357460. eCollection 2022.
5
Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.
JAMA Intern Med. 2022 Feb 1;182(2):197-205. doi: 10.1001/jamainternmed.2021.7949.
7
Modifiable Risk Factors for SARS-CoV-2.
Integr Med (Encinitas). 2021 Oct;20(5):8-14.
8
Diet quality and risk and severity of COVID-19: a prospective cohort study.
Gut. 2021 Nov;70(11):2096-2104. doi: 10.1136/gutjnl-2021-325353. Epub 2021 Sep 6.
9
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Nat Immunol. 2021 Nov;22(11):1428-1439. doi: 10.1038/s41590-021-01028-7. Epub 2021 Sep 1.
10
A randomized trial of icosapent ethyl in ambulatory patients with COVID-19.
iScience. 2021 Sep 24;24(9):103040. doi: 10.1016/j.isci.2021.103040. Epub 2021 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验